December 12, 2024

Collaborative success: Long-term business partner utilizes our TMB PLUS2® in research!

Dr. Jean Amiral, our long-term business partner, has been working with our products for more than 20 years. In a recent study, conducted in collaboration with two other talented scientists, Dr. Amiral utilized our TMB PLUS2® to explore the role of anti-Annexin A1 autoantibodies in COVID-19 patients.

The study revealed a significant link between these autoantibodies and disease severity, including thrombosis and ICU admissions, providing valuable insights into inflammatory processes and biomarker discovery.

We are honored to see our reliable TMB PLUS2® supporting innovative research and advancing diagnostics for complex diseases like COVID-19.

Read the full study here:

Stack of books with a cup of coffee